{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:22:22Z","timestamp":1780348942052,"version":"3.54.1"},"reference-count":27,"publisher":"American Association for Cancer Research (AACR)","issue":"20","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Among the many proteases associated with human cancer, seprase or fibroblast activation protein \u03b1, a type II transmembrane glycoprotein, has two types of EDTA-resistant protease activities: dipeptidyl peptidase and a 170-kDa gelatinase activity. To test if activation of gelatinases associated with seprase could be involved in malignant tumors, we used a mammalian expression system to generate a soluble recombinant seprase (r-seprase). In the presence of putative EDTA-sensitive activators, r-seprase was converted into 70- to 50-kDa shortened forms of seprase (s-seprase), which exhibited a 7-fold increase in gelatinase activity, whereas levels of dipeptidyl peptidase activity remained unchanged. In malignant human tumors, seprase is expressed predominantly in tumor cells as shown by in situ hybridization and immunohistochemistry. Proteins purified from experimental xenografts and malignant tumors using antibody- or lectin-affinity columns in the presence of 5 mmol\/L EDTA were assayed for seprase activation in vivo. Seprase expression and activation occur most prevalently in ovarian carcinoma but were also detected in four other malignant tumor types, including adenocarcinoma of the colon and stomach, invasive ductal carcinoma of the breast, and malignant melanoma. Together, these data show that, in malignant tumors, seprase is proteolytically activated to confer its substrate specificity in collagen proteolysis and tumor invasion. (Cancer Res 2006; 66(20): 9977-85)<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-1499","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T09:42:10Z","timestamp":1161164530000},"page":"9977-9985","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Activation of EDTA-Resistant Gelatinases in Malignant Human Tumors"],"prefix":"10.1158","volume":"66","author":[{"given":"Donghai","family":"Chen","sequence":"first","affiliation":[{"name":"1Medicine and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanna","family":"Kennedy","sequence":"additional","affiliation":[{"name":"1Medicine and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaw-Yuan","family":"Wang","sequence":"additional","affiliation":[{"name":"1Medicine and Departments of"},{"name":"3Department of Surgery, Kaohsiung Medical University, Kaohsiung, Taiwan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zeng","sequence":"additional","affiliation":[{"name":"1Medicine and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhao","sequence":"additional","affiliation":[{"name":"1Medicine and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pearl","sequence":"additional","affiliation":[{"name":"2Obstetrics, Gynecology, and Reproductive Medicine, Stony Brook University, Stony Brook, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhen","family":"Zhang","sequence":"additional","affiliation":[{"name":"4Department of Pathology, The National Hospital-The Norwegian Radium Hospital, University of Oslo, Oslo, Norway;"},{"name":"5Department of Gynecology and Obstetrics, Zhengzhou University, Henan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhe","family":"Suo","sequence":"additional","affiliation":[{"name":"4Department of Pathology, The National Hospital-The Norwegian Radium Hospital, University of Oslo, Oslo, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahn M.","family":"Nesland","sequence":"additional","affiliation":[{"name":"4Department of Pathology, The National Hospital-The Norwegian Radium Hospital, University of Oslo, Oslo, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuan","family":"Qiao","sequence":"additional","affiliation":[{"name":"5Department of Gynecology and Obstetrics, Zhengzhou University, Henan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ah-Kau","family":"Ng","sequence":"additional","affiliation":[{"name":"6Department of Applied Medical Science, University of Southern Maine, Portland, Maine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Hirashima","sequence":"additional","affiliation":[{"name":"7Department of Pathology, Faculty of Medicine, Yamanashi Medical University, Shimokato Tamaho Nakakoma, Yamanashi, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Yamane","sequence":"additional","affiliation":[{"name":"7Department of Pathology, Faculty of Medicine, Yamanashi Medical University, Shimokato Tamaho Nakakoma, Yamanashi, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Mori","sequence":"additional","affiliation":[{"name":"7Department of Pathology, Faculty of Medicine, Yamanashi Medical University, Shimokato Tamaho Nakakoma, Yamanashi, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Mitsumata","sequence":"additional","affiliation":[{"name":"7Department of Pathology, Faculty of Medicine, Yamanashi Medical University, Shimokato Tamaho Nakakoma, Yamanashi, Japan;"},{"name":"8Department of Pathology, School of Medicine, Nihon University, Itabashi, Tokyo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Ghersi","sequence":"additional","affiliation":[{"name":"9Dipartimento di Biologia Cellulare e dello Sviluppo, Universita\u0300 di Palermo, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Tien","family":"Chen","sequence":"additional","affiliation":[{"name":"1Medicine and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,10,17]]},"reference":[{"key":"2022061622280702500_B1","doi-asserted-by":"crossref","unstructured":"Aoyama A, Chen W-T. A 170-kDa membrane-bound protease is associated with the expression of invasiveness by human malignant melanoma cells. Proc Natl Acad Sci U S A\u20081990; 87: 8296\u2013300.","DOI":"10.1073\/pnas.87.21.8296"},{"key":"2022061622280702500_B2","unstructured":"Monsky WL, Lin C-Y, Aoyama A, et al. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res\u20081994; 54: 5702\u201310."},{"key":"2022061622280702500_B3","doi-asserted-by":"crossref","unstructured":"Pineiro-Sanchez ML, Goldstein LA, Dodt J, et al. Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease. Correction (1998) J Biol Chem 273, 13366. J Biol Chem\u20081997; 272: 7595\u2013601.","DOI":"10.1074\/jbc.272.12.7595"},{"key":"2022061622280702500_B4","doi-asserted-by":"crossref","unstructured":"Goldstein LA, Ghersi G, Pin\u0303eiro-Sa\u0301nchez ML, et al. Molecular cloning of seprase: a serine integral membrane protease from human melanoma. Biochim Biophys Acta\u20081997; 1361: 11\u20139.","DOI":"10.1016\/S0925-4439(97)00032-X"},{"key":"2022061622280702500_B5","doi-asserted-by":"crossref","unstructured":"Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem\u20081999; 274: 36505\u201312.","DOI":"10.1074\/jbc.274.51.36505"},{"key":"2022061622280702500_B6","doi-asserted-by":"crossref","unstructured":"Scanlan MJ, Raj BK, Calvo B, et al. Molecular cloning of fibroblast activation protein \u03b1, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci U S A\u20081994; 91: 5657\u201361.","DOI":"10.1073\/pnas.91.12.5657"},{"key":"2022061622280702500_B7","doi-asserted-by":"crossref","unstructured":"Goldstein LA, Chen W-T. Identification of an alternatively spliced seprase mRNA that encodes a novel intracellular isoform. J Biol Chem\u20082000; 275: 2554\u20139.","DOI":"10.1074\/jbc.275.4.2554"},{"key":"2022061622280702500_B8","doi-asserted-by":"crossref","unstructured":"Ariga N, Sato E, Ohuchi N, Nagura H, Ohtani H. Stromal expression of fibroblast activation protein\/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast. Int J Cancer\u20082001; 95: 67\u201372.","DOI":"10.1002\/1097-0215(20010120)95:1<67::AID-IJC1012>3.0.CO;2-U"},{"key":"2022061622280702500_B9","doi-asserted-by":"crossref","unstructured":"Huang Y, Wang S, Kelly T. Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer. Cancer Res\u20082004; 64: 2712\u20136.","DOI":"10.1158\/0008-5472.CAN-03-3184"},{"key":"2022061622280702500_B10","unstructured":"Kelly T, Kechelava S, Rozypal TL, West KW, Korourian S. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. Mod Pathol\u20081998; 11: 855\u201363."},{"key":"2022061622280702500_B11","doi-asserted-by":"crossref","unstructured":"Okada K, Chen W-T, Iwasa S, et al. Seprase, a membrane-type serine protease, has different expression patterns in intestinal- and diffuse-type gastric cancer. Oncology\u20082003; 65: 363\u201370.","DOI":"10.1159\/000074650"},{"key":"2022061622280702500_B12","doi-asserted-by":"crossref","unstructured":"Mori Y, Kono K, Matsumoto Y, et al. The expression of a type II transmembrane serine protease (seprase) in human gastric carcinoma. Oncology\u20082004; 67: 411\u20139.","DOI":"10.1159\/000082926"},{"key":"2022061622280702500_B13","doi-asserted-by":"crossref","unstructured":"Iwasa S, Okada K, Chen W-T, et al. Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer. Cancer Lett\u20082005; 227: 229\u201336.","DOI":"10.1016\/j.canlet.2004.06.030"},{"key":"2022061622280702500_B14","unstructured":"Jin X, Iwasa S, Okada K, Mitsumata M, Ooi A. Expression patterns of seprase, a membrane serine protease, in cervical carcinoma and cervical intraepithelial neoplasm. Anticancer Res\u20082003; 23: 3195\u20138."},{"key":"2022061622280702500_B15","doi-asserted-by":"crossref","unstructured":"Ghersi G, Dong H, Goldstein LA, et al. Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex. J Biol Chem\u20082002; 277: 29231\u201341.","DOI":"10.1074\/jbc.M202770200"},{"key":"2022061622280702500_B16","doi-asserted-by":"crossref","unstructured":"Mueller SC, Ghersi G, Akiyama SK, et al. A novel protease-docking function of integrin at invadopodia. J Biol Chem\u20081999; 274: 24947\u201352.","DOI":"10.1074\/jbc.274.35.24947"},{"key":"2022061622280702500_B17","doi-asserted-by":"crossref","unstructured":"Cheng JD, Valianou M, Canutescu AA, et al. Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth. Mol Cancer Ther\u20082005; 4: 351\u201360.","DOI":"10.1158\/1535-7163.MCT-04-0269"},{"key":"2022061622280702500_B18","unstructured":"Cheng JD, Dunbrack RL, Jr., Valianou M, Rogatko A, Alpaugh RK, Weiner LM. Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res\u20082002; 62: 4767\u201372."},{"key":"2022061622280702500_B19","doi-asserted-by":"crossref","unstructured":"Ramirez-Montagut T, Blachere NE, Sviderskaya EV, et al. FAP\u03b1, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene\u20082004; 23: 5435\u201346.","DOI":"10.1038\/sj.onc.1207730"},{"key":"2022061622280702500_B20","doi-asserted-by":"crossref","unstructured":"Rettig WJ, Su SL, Fortunato SR, et al. Fibroblast activation protein: purification, epitope mapping and induction by growth factors. Int J Cancer\u20081994; 58: 385\u201392.","DOI":"10.1002\/ijc.2910580314"},{"key":"2022061622280702500_B21","doi-asserted-by":"crossref","unstructured":"Levy MT, McCaughan GW, Abbott CA, et al. Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology\u20081999; 29: 1768\u201378.","DOI":"10.1002\/hep.510290631"},{"key":"2022061622280702500_B22","doi-asserted-by":"crossref","unstructured":"Niedermeyer J, Enenkel B, Park JE, et al. Mouse fibroblast-activation protein-conserved Fap gene organization and biochemical function as a serine protease. Eur J Biochem\u20081998; 254: 650\u20134.","DOI":"10.1046\/j.1432-1327.1998.2540650.x"},{"key":"2022061622280702500_B23","doi-asserted-by":"crossref","unstructured":"Aertgeerts K, Levin I, Shi L, et al. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein \u03b1. J Biol Chem\u20082005; 280: 19441\u20134.","DOI":"10.1074\/jbc.C500092200"},{"key":"2022061622280702500_B24","doi-asserted-by":"crossref","unstructured":"Bjelke JR, Christensen J, Branner S, et al. Tyrosine 547 constitutes an essential part of the catalytic mechanism of dipeptidyl peptidase IV. J Biol Chem\u20082004; 279: 34691\u20137.","DOI":"10.1074\/jbc.M405400200"},{"key":"2022061622280702500_B25","doi-asserted-by":"crossref","unstructured":"Chen W-T, Yeh Y, Nakahara H. An in vitro cell invasion assay: determination of cell surface proteolytic activity that degrades extracellular matrix. J Tiss Cult Meth\u20081994; 16: 177\u201381.","DOI":"10.1007\/BF01540646"},{"key":"2022061622280702500_B26","unstructured":"Gladson CL, Pijuan-Thompson V, Olman MA, Gillespie GY, Yacoub IZ. Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma. Am J Pathol\u20081995; 146: 1150\u201360."},{"key":"2022061622280702500_B27","doi-asserted-by":"crossref","unstructured":"Saffarian S, Collier IE, Marmer BL, Elson EL, Goldberg G. Interstitial collagenase is a Brownian ratchet driven by proteolysis of collagen. Science\u20082004; 306: 108\u201311.","DOI":"10.1126\/science.1099179"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/20\/9977\/2555080\/9977.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/20\/9977\/2555080\/9977.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T01:46:41Z","timestamp":1655430401000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/20\/9977\/526323\/Activation-of-EDTA-Resistant-Gelatinases-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,15]]},"references-count":27,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2006,10,17]]},"published-print":{"date-parts":[[2006,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-1499","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,15]]}}}